Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma

por Lee, Jan-Mou, Hung, Yi-Ping, Chou, Kai-Yuan, Lee, Cheng-Yun, Lin, Shian-Ren, Tsai, Ya-Han, Lai, Wan-Yu, Shao, Yu-Yun, Hsu, Chiun, Hsu, Chih-Hung, Chao, Yee
Publicado 2022